医学
梗阻性心肌病
肥厚性心肌病
心脏病学
内科学
心肌病
心力衰竭
作者
Charles F Sherrod,Sara Saberi,Michael E. Nassif,Brian Claggett,Caroline Coats,Pablo García‐Pavía,James L. Januzzi,Gregory D. Lewis,Changsheng Ma,Martin S. Maron,Zi Michael Miao,Iacopo Olivotto,Josef Veselka,Michael Butzner,Daniel Jacoby,Stephen B. Heitner,Stuart Kupfer,Fady I. Malik,Lisa Meng,Amy Wohltman
标识
DOI:10.1016/j.jacc.2024.08.014
摘要
In patients with symptomatic oHCM, treatment with aficamten resulted in markedly improved health status, including significant improvement in chest pain-related health status, than placebo. (Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM [SEQUOIA-HCM]; NCT05186818).
科研通智能强力驱动
Strongly Powered by AbleSci AI